Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 270, pseudogene (RN7SL270P)

Target
RN7SL270P
Molecular classification
Other (pseudogene, noncoding RNA-derived pseudogene)
01

Overview

RN7SL270P is a processed pseudogene derived from the 7SL RNA gene, encoding a noncoding RNA component of the signal recognition particle (SRP). The original 7SL RNA is essential for SRP-mediated targeting of nascent proteins to the endoplasmic reticulum membrane in eukaryotes[1][3][5]. 7SL pseudogenes, like RN7SL270P, are generated by retrotransposition events and are scattered throughout the genome as truncated or mutated copies of the parental 7SL RNA gene; they lack the promoter and regulatory sequences necessary for functional transcription[1]. While most pseudogenes are nonfunctional, some have been reported to regulate gene expression by acting as competing endogenous RNAs or via antisense RNA effects in other gene families, but there are no established biological or clinical roles for RN7SL270P[2][3]. RN7SL pseudogenes are best described as genomic fossils without protein-coding potential or receptor activity, and the inclusion of RN7SL270P as a therapeutic target or receptor is scientifically incorrect[1][2][5].

Other names
7SL RNA pseudogene7SL pseudogenecytoplasmic 270 pseudogene
02

Mechanism of action

None (no drugs or therapies act via RN7SL pseudogenes).

03

Biological functions

Most pseudogenes have no direct biological function, but rare pseudogene transcripts can act as gene expression regulators (e.g., antisense RNA, miRNA sponges) in some contexts. For RN7SL pseudogenes, no well-established biological function is reported.
04

Disease associations

Other (No known disease association; however, general roles for some pseudogenes in cancer and other diseases have been described, but not for RN7SL270P specifically)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 270, pseudogene (RN7SL270P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 270, pseudogene (RN7SL270P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call